{"schemaVersion":"peptidescanner-clinical-trials-history-object/v1","objectId":"clinical-trials-history:NCT02944500","recordId":"NCT02944500","peptideSlug":"liraglutide","publishedAt":"2026-08-23","sourceObservedAt":"2026-08-23T23:32:33.000Z","sourceObservationSha256":"6ae8058d20bbb511d9250d19ac0bd3475945bb56f0057fdb437648218b72606e","urls":{"human":"https://peptidescanner.com/stories/clinicaltrials-gov-nct02944500-liraglutide/","json":"https://peptidescanner.com/clinical-trials-history/v1/trials/nct02944500.json","markdown":"https://peptidescanner.com/clinical-trials-history/v1/trials/nct02944500.md"},"reportingBoundary":"ClinicalTrials.gov lists this public record-history version and identifies its submitted date and the source modules marked as changed. PeptideScanner does not infer what changed inside a module, why it changed, whether the change is material, whether the study is trustworthy, or whether an intervention is safe or effective.","versions":[{"changedModules":[],"historyVersion":1,"lastUpdateSubmitQcDate":"2016-10-24","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"NOT_YET_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2016-10-24","publishedAt":"2026-08-23","recordId":"NCT02944500","recordSha256":"9fa7f12cf6f68bedb56584dcdf652f6f2af9827fb8a69fb40eb7c4eb7ef77891","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02944500?a=1&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Arms and Interventions","Study Status"],"historyVersion":2,"lastUpdateSubmitQcDate":"2016-11-15","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"NOT_YET_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2016-11-15","publishedAt":"2026-08-23","recordId":"NCT02944500","recordSha256":"8ce4e4247234293514af40fb718c1126e9bb1a5047fc6655f839761175e16b4e","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02944500?a=2&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":3,"lastUpdateSubmitQcDate":"2017-01-05","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2017-01-05","publishedAt":"2026-08-23","recordId":"NCT02944500","recordSha256":"3c8130e248f68f3401849fbef833b75734b65f8f0b8c6f4236fc5a3d1b813d34","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02944500?a=3&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Sponsor/Collaborators","Study Design","Study Status"],"historyVersion":4,"lastUpdateSubmitQcDate":"2017-01-25","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2017-01-25","publishedAt":"2026-08-23","recordId":"NCT02944500","recordSha256":"400a5d877be1b315ebafb12f4b2ad3a85c7390c6406ac4d9a251db14951c7519","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02944500?a=4&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":5,"lastUpdateSubmitQcDate":"2018-02-16","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2018-02-16","publishedAt":"2026-08-23","recordId":"NCT02944500","recordSha256":"c0732814bc52d8f90b5d53bdad7f88c0dab524f943ee253be2389276bfab3f9d","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02944500?a=5&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":6,"lastUpdateSubmitQcDate":"2019-01-25","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2019-01-25","publishedAt":"2026-08-23","recordId":"NCT02944500","recordSha256":"7b19ae727096cf4d59d2756252ca9fd139e4a0e22fa2d6daf3f27fa8a7da3e67","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02944500?a=6&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Design","Study Status"],"historyVersion":7,"lastUpdateSubmitQcDate":"2019-04-05","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2019-04-05","publishedAt":"2026-08-23","recordId":"NCT02944500","recordSha256":"cd8946530f90969dea8727bd6a5a2cca1c682fcdda002d971686478346d502b2","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02944500?a=7&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Sponsor/Collaborators","Study Status"],"historyVersion":8,"lastUpdateSubmitQcDate":"2020-06-24","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2020-06-24","publishedAt":"2026-08-23","recordId":"NCT02944500","recordSha256":"9bb3865794f0c0ad6c404c8e197b91b3b0332976cfda893e147d0ef7a846d44e","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02944500?a=8&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Sponsor/Collaborators","Study Status"],"historyVersion":9,"lastUpdateSubmitQcDate":"2021-01-19","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2021-01-19","publishedAt":"2026-08-23","recordId":"NCT02944500","recordSha256":"81e09467c55aa92a3d628b104f5767ad336b131eb5e018d13203644e8788c77f","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02944500?a=9&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Description","Study Status"],"historyVersion":10,"lastUpdateSubmitQcDate":"2022-07-18","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2022-07-18","publishedAt":"2026-08-23","recordId":"NCT02944500","recordSha256":"3802fa5a2c6c09db1ff15b7592e3d255b3e257fcea7ca8a1bec1bc6b558d5aec","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02944500?a=10&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":11,"lastUpdateSubmitQcDate":"2023-08-09","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2023-08-09","publishedAt":"2026-08-23","recordId":"NCT02944500","recordSha256":"90bd7b9e56213e9b8d89734be2c1d99827a1e191423c6ff6996247b1059e651b","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02944500?a=11&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":12,"lastUpdateSubmitQcDate":"2024-09-27","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2024-09-27","publishedAt":"2026-08-23","recordId":"NCT02944500","recordSha256":"d702f09d8d3d8b37c958678db1bc049b4ee4126cb268d8b66b27c85de541b2b9","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02944500?a=12&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":13,"lastUpdateSubmitQcDate":"2025-03-19","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2025-03-19","publishedAt":"2026-08-23","recordId":"NCT02944500","recordSha256":"ae12c1f19f2997337199fdf9db29ba38602f3a363589ca04cd04d49c2389b127","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02944500?a=13&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":14,"lastUpdateSubmitQcDate":"2026-04-27","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2026-04-27","publishedAt":"2026-08-23","recordId":"NCT02944500","recordSha256":"14d8d414a444d5581f78d38eb3659010651a288efc61ed177521358e83ab5953","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02944500?a=14&tab=history","studyType":"INTERVENTIONAL"}],"integrity":{"algorithm":"sha256","contentSha256":"d919084a1368df2aafed000be9ce0b1a78018ffe4d04e04edf1fcda97a14dee9"}}